Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients: a case control study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2047-783X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients: a case control study ; volume:17 ; number:1 ; day:30 ; month:1 ; year:2012 ; pages:1-6 ; date:12.2012
European journal of medical research ; 17, Heft 1 (30.1.2012), 1-6, 12.2012
- Creator
- Contributor
- DOI
-
10.1186/2047-783X-17-2
- URN
-
urn:nbn:de:1111-2016073148688
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fricke, Ulrich
- Geurtsen, Werner
- Staufenbiel, Ingmar
- Rahman, Alexander
- SpringerLink (Online service)
Other Objects (12)
Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients : a case control study
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Interferon-Containing and Interferon-Free HCV Therapy for HIV-Infected Patients
Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy
Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Subclinical kidney disease in HIV-infected patients
Hepatitis B coinfection in HIV-infected patients
A multidisciplinary staff for the optimisation of therapy in HIV-infected patients treated for cancer
Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients : a case control study
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Interferon-Containing and Interferon-Free HCV Therapy for HIV-Infected Patients
Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy
Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Subclinical kidney disease in HIV-infected patients
Hepatitis B coinfection in HIV-infected patients
A multidisciplinary staff for the optimisation of therapy in HIV-infected patients treated for cancer
Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era
Periodontal status of HIV-infected patients undergoing antiretroviral therapy compared to HIV-therapy naive patients : a case control study
Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Interferon-Containing and Interferon-Free HCV Therapy for HIV-Infected Patients
Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy
Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients
Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
Subclinical kidney disease in HIV-infected patients
Hepatitis B coinfection in HIV-infected patients
A multidisciplinary staff for the optimisation of therapy in HIV-infected patients treated for cancer